富国中证医药主题指数增强C(005626)利润分配表
| |
2025-06-30 |
2024-12-31 |
2024-06-30 |
2023-12-31 |
| 收入 |
44,762,476.02 |
-83,296,210.63 |
-107,962,624.60 |
-25,793,426.01 |
| 利息合计 |
44,884.60 |
111,108.26 |
65,802.93 |
606,590.37 |
| 其中：存款利息收入 |
44,884.60 |
90,830.72 |
45,533.34 |
307,462.91 |
| 债券利息收入 |
- |
- |
- |
- |
| 资产支持证券利息收入 |
- |
- |
- |
- |
| 买入返售金融资产收入 |
- |
- |
- |
- |
| 投资收益合计 |
16,091,570.57 |
-89,813,560.11 |
-72,255,526.06 |
-43,812,135.12 |
| 其中：股票投资收益 |
11,704,789.12 |
-97,741,306.82 |
-76,845,818.73 |
-51,044,507.20 |
| 基金投资收益 |
- |
- |
- |
- |
| 债券投资收益 |
-9,327.52 |
349,639.52 |
204,631.10 |
189,730.89 |
| 资产支持证券投资收益 |
- |
- |
- |
- |
| 衍生工具收益 |
- |
- |
- |
- |
| 股利收益 |
4,396,108.97 |
7,578,107.19 |
4,385,661.57 |
7,042,641.19 |
| 基金分红收益收益 |
- |
- |
- |
- |
| 公允价值变动收益 |
28,440,247.45 |
6,241,959.12 |
-35,841,248.94 |
17,189,436.23 |
| 其他收入 |
185,773.40 |
164,282.10 |
68,347.47 |
222,682.51 |
| 费用 |
3,339,864.27 |
7,504,166.81 |
4,029,491.24 |
8,994,644.40 |
| 管理人报酬 |
2,737,763.46 |
5,983,940.11 |
3,208,929.38 |
7,228,883.57 |
| 基金托管费 |
456,293.92 |
997,323.43 |
534,821.62 |
1,204,813.93 |
| 销售服务费 |
50,638.74 |
159,170.23 |
103,934.09 |
195,432.41 |
| 交易费用 |
- |
- |
- |
- |
| 利息支出 |
- |
- |
- |
- |
| 其中：卖出回购金融资产支出 |
- |
- |
- |
- |
| 其他费用 |
95,168.15 |
363,660.00 |
181,733.18 |
364,437.26 |
| 利润总额 |
41,422,611.75 |
-90,800,377.44 |
-111,992,115.84 |
-34,788,070.41 |
微信公众号
证券之星APP
基本资料
